Revolution Medicines (RVMD) Financials: Revenue & Earnings

RVMD$199.70—
BiotechnologyLarge CapGrowth Stock
Compare
Market cap$34.87BEnterprise value—Revenue (TTM)$197.56MMarket positionTop 25%

Score

56
Neutral
Value
49
Quality
21
Growth
97

Financial Summary

Revolution Medicines, Inc. (RVMD) last printed $199.70. Equity value is $34.87B. Trailing earnings multiple —. The revenue row is reported history.

Financials

201720182019202020212022202320242025
$0.00$20.16M$50.04M$42.98M$29.39M$35.38M$11.58M$0.00$0.00

Revolution Medicines (RVMD) Financials: Revenue & Earnings

RVMD price $199.70 —

Ticker
RVMD
Price
$199.70
Change
—
Market cap
$34.87B
Dividend yield
0.00%
Beta
1.43
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
56
Value
49
Quality
21
Growth
97

Stocklytics score rationale: value 49, quality 21, growth 97.

AI Score 35. Revolution Medicines, Inc. has a high price of $199.7 with a market cap of $42.8 billion, but it is in the clinical development stage with significant negative margins, including a net profit margin of -9.5%

Insights · Forecast · Financials · Learn

Stocklytics home · Screener